Your browser doesn't support javascript.
loading
Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy.
Ghalandari, Nafise; Kemper, Erik; Crijns, Ineke Hubertina; Wolbink, Gertjan; Rispens, Theo; Smeele, Hieronymus Tw; Dolhain, Radboud Jem.
Afiliação
  • Ghalandari N; Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands n.ghalandari@erasmusmc.nl.
  • Kemper E; FT1/GMB, Medicines Evaluation Board, Utrecht, The Netherlands.
  • Crijns IH; Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Wolbink G; FT1/GMB, Medicines Evaluation Board, Utrecht, The Netherlands.
  • Rispens T; FT1/GMB, Medicines Evaluation Board, Utrecht, The Netherlands.
  • Smeele HT; Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands.
  • Dolhain RJ; Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands.
Ann Rheum Dis ; 81(3): 402-405, 2022 03.
Article em En | MEDLINE | ID: mdl-34493490
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações na Gravidez / Artrite Reumatoide / Reumatologia / Sangue Fetal / Inibidores do Fator de Necrose Tumoral Limite: Adult / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações na Gravidez / Artrite Reumatoide / Reumatologia / Sangue Fetal / Inibidores do Fator de Necrose Tumoral Limite: Adult / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article